An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitis

Clinical trial NCT03290781 · COMPLETED

Trial details

NCT number: NCT03290781
Sponsor: Shire
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Ulcerative Colitis

Start date: 2018-04-04
Primary completion: 2021-07-01
Enrollment: 366

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.